NRP1 antagonist 1
Zilucoplan
Vesencumab
Tesidolumab
Ravulizumab
Lampalizumab
Vilobelimab
Avdoralimab
Pexelizumab
Gefurulimab
Gavilimomab
Olendalizumab
Pozelimab
Crovalimab
Riliprubart
Empasiprubart
Zoracopan
Sutimlimab
BCX 1470
PMX 205